Any number of things such as stress, spicy foods and more can cause heartburn. Many people across the country and here in Ohio used to take medications containing ratinidine for this condition, which is the main ingredient in over-the-counter drugs such as Zantac. When the Zantac recall began, people were forced to find other options, and they continue to get smaller as options dwindle.
By now, most people here in Ohio have heard of the problem with heartburn medications containing rantidine, including Zantac. Testing indicates these medications contain unsafe levels of NDMA, which is a probable human carcinogen. Recently, the Food and Drug Administration ordered the recall of all rantidine products from the market. Now, yet another heartburn medication is being recalled due to the presence of NDMA.
People across the country and here in Ohio continue to suffer from gastrointestinal ailments such as ulcers and acid reflux despite the recent removal of medications containing ranitidine from the market. In the wake of the Zantac recall, people turned to other medications to deal with these ailments. The problem is that now people may have to find yet another alternative to treat these conditions due to the recall of yet another medication.
In the midst of everything else going on here in Ohio and across the country, the Food and Drug Administration still has to fulfill its obligations to the public, which means keeping track of dangerous and defective products and medications. As part of this ongoing mission, the FDA recently announced that it requested all manufacturers to initiate an immediate and complete ranitidine recall. This would take all medications containing it off the market.
Along with everyone else in the country, Ohio residents have bigger concerns than what is happening with heartburn medications. However, it is still important to keep up to date on ranitidine recalls, especially for those who are having issues due to stress. Some people may be surprised to learn that testing and the investigation into the presence of N-Nitrosodimethylamine, or NDMA, continues regardless of what else may be going on right now.
Multiple consumers of Zantac, a popular heartburn relief medication, have filed claims against the drug manufacturers claiming use of the medication led to the development of cancer. In February, The Judicial Panel for Multi District Litigation assigned all of the cases across the country to Judge Rosenberg in the U. S. District Court for the Southern District of Florida in Palm Beach.
Ohio residents used to trust that the medications prescribed to or purchased by them were safe. The blood pressure and Zantac recall issues over the last couple of years could now cause many people to question the safety of the both over-the-counter and prescribed medications. One question now former Zantac users may have is whether there was a breakdown in the drug review process conducted by the Food and Drug Administration.
Since Sept. 2019, more and more drug recalls have surfaced regarding heartburn medications containing ranitidine, the most popular of which is Zantac. Once the recalls started, they continued to expand to include nearly all brands of this medication.
Since the recalls of products containing ranitidine began last year, the Food and Drug Administration, along with consumers here in Ohio and elsewhere, pharmaceutical companies and researchers have been asking why N-nitrosodimethylamine was found in unsafe concentrations in the popular heartburn medication. Now, there could finally be some clues as to why the Zantac debacle occurred. Emery Pharma's initial reports may provide promising answers, which could ultimately reveal how to make the medication safe again.